Enzyme vs Modell Aachen GmbH: Revenue, Funding & Team Size Compared
Enzyme generates $10.3M in revenue; Modell Aachen GmbH generates $10M. Enzyme and Modell Aachen GmbH are close to the same size by revenue. The table below compares Enzyme and Modell Aachen GmbH on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  EnzymeThis company |  Modell Aachen GmbH |
|---|---|---|
| Revenue | $10.3M | $10M |
| Valuation | $61.6M | $70.2M |
| Funding raised | $2M | Not disclosed |
| Customers | 21 | 750 |
| Team size | 33 | 60 |
| Founded | 2018 | 2009 |
| HQ | San Francisco, United States | Aachen, Germany |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Enzyme at a glance
Enzyme generates $10.3M in revenue with 33 employees, headquartered in San Francisco, United States.
- Revenue
- $10.3M
- Valuation
- $61.6M
- Funding
- $2M
- Customers
- 21
- Team size
- 33
- Founded
- 2018
Automating FDA approval and compliance
Modell Aachen GmbH at a glance
Modell Aachen GmbH generates $10M in revenue with 60 employees, headquartered in Aachen, Germany.
- Revenue
- $10M
- Valuation
- $70.2M
- Customers
- 750
- Team size
- 60
- Founded
- 2009
Software for Interactive Management Systems (e.g. ISO 9001, ISO 27001, BPM, Comliance).
Other Enzyme alternatives
Enzyme competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Enzyme vs Modell Aachen GmbH: frequently asked questions
Is Enzyme or Modell Aachen GmbH bigger?
Enzyme is the bigger company by revenue, at $10.3M against $10M for Modell Aachen GmbH.
How much revenue does Enzyme make?
Enzyme generates $10.3M in annual revenue with a team of 33.
How much revenue does Modell Aachen GmbH make?
Modell Aachen GmbH generates $10M in annual revenue with a team of 60.
How much funding has Enzyme raised?
Enzyme has raised $2M in total funding since it was founded in 2018.